Heteroaryloxy nitrogenous saturated heterocyclic derivative
US8044070B2 · kind B2 · utility
0Cited by
7References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2009 |
| Grant date | Oct 25, 2011 |
| Priority date | — |
| Expiry date | Sep 9, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compounds of a formula (I) and their pharmaceutically-acceptable salts:wherein X1, X2 and X3 each independently represent N or CH; W represents the following formula (II):or the following formula (III):Y represents a group of a formula (IV):The compounds have a histamine-H3 receptor antagonistic or inverse-agonistic activity and are useful for remedy and/or prevention of obesity, diabetes, hormone secretion disorders, sleep disorders, etc.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.